医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Zelis® Earns 2024 Great Place to Work® Certification in India

2024年07月09日 AM11:30
このエントリーをはてなブックマークに追加


 

HYDERABAD, India

Zelis, a leading provider of healthcare technology solutions, achieves Great Place to Work certification in India for the first time. The honor was determined based on local associates’ survey responses related to their experience at Zelis, the workplace culture, and their perception of Company leadership.

“It is an exciting time to be at Zelis and to be part of our growing team in India,” says Venu Kandimalla, SVP and General Manager of Zelis India. “Over the past year, we’ve successfully expanded our team and local operations. To be recognized as a regional workplace leader is a testament to the commitment of our associates and the special environment they have created in India.”

For Zelis India, the Great Place to Work certification comes just one year after the founding of the local office in Hyderabad, India. Zelis stood out for its ability to deliver exceptional development, learning, wellness, recognition, and corporate giving programs. The Company’s continued commitment to diversity, equity, inclusion, and belonging also separates it from others in the healthcare market. The recognition comes after Zelis celebrated its Great Place to Work certification in the United States for a second consecutive year.

Learn more about the award-winning Zelis culture and explore our current career opportunities.

About Zelis

Zelis is modernizing the healthcare financial experience by providing a connected platform that bridges the gaps and aligns interests across payers, providers, and healthcare consumers. This platform serves more than 750 payers, including the top 5 national health plans, BCBS insurers, regional health plans, TPAs and self-insured employers, and millions of healthcare providers and consumers. Zelis sees across the system to identify, optimize, and solve problems holistically with technology built by healthcare experts – driving real, measurable results for clients. Learn more at Zelis.com and follow us on LinkedIn to get the latest news.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240708680071/en/

CONTACT

Jon Gregalis

press [at] zelis.com

同じカテゴリーの記事 

  • Medidata在Everest Group的首个电子数据采集PEAK Matrix®评估中被评为领导者
  • メディデータが、エベレスト・グループ初の電子データキャプチャPEAK Matrix®評価でリーダーとして認定
  • ケイティ・クレイマー、 パース・バイオサイエンシズのマーケティング・バイスプレジデントに就任
  • Kaitie Kramer加入Parse Biosciences担任营销副总裁
  • Zai Lab to Present Preclinical Data of ZL-1503, an IL-13/IL-31 Bispecific Antibody for the Treatment of Atopic Dermatitis, at EADV Congress 2024